Management and Treatment of Patients With Major Depressive Disorder and Chronic Diseases: A Multidisciplinary

Susana Sousa Almeida1, Francesca Benedetta Zizzi2, Agnese Cattaneo3

  • 1Portuguese Institute of Oncology Porto (IPO Porto), Hospital Cuf Porto (HCuf Porto), University of Porto (FMUP), Porto, Portugal.

Frontiers in Psychology
|October 26, 2020
PubMed

Insights

Major depressive disorder (MDD) is common in chronic physical diseases, impacting quality of life and increasing healthcare costs. A personalized, multidisciplinary approach can improve patient compliance and outcomes.

Area of Science:

  • Clinical Medicine
  • Psychiatry
  • Public Health

Background:

  • Major Depressive Disorder (MDD) prevalence is 2-3x higher in chronic physical disease patients (up to 20-40%).
  • Comorbidity of MDD with chronic illness leads to reduced quality of life, increased symptom burden, poor adherence, functional impairment, and higher mortality.
  • Psychological aspects of chronic diseases are often inadequately addressed in routine clinical practice.

Purpose of the Study:

  • To propose a consensus for managing patients with Major Depressive Disorder (MDD) and chronic medical comorbidities.
  • To emphasize the importance of integrated care for improving patient outcomes and reducing healthcare burdens.

Main Methods:

  • This document is a consensus proposal based on existing evidence regarding MDD and chronic diseases.
  • It outlines a framework for healthcare professionals managing these complex patient cases.

Main Results:

  • A structured approach involving proper diagnosis, multidisciplinary teams, and personalized treatment plans is recommended.
  • This strategy aims to enhance patient compliance, improve treatment outcomes, and reduce long-term relapses and complications.

Conclusions:

  • Effective management of MDD in patients with chronic physical diseases requires a shift towards integrated and personalized care.
  • Healthcare professionals should proactively address the emotional impact of chronic conditions, particularly depressive symptoms.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
629
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
465
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
604